slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 234,901-234,930
Pages 10,126
Rows per page 30
Component
234,901-234,930 of 303,780
49
The chart uses a bridge/waterfall structure to show revenue growth drivers.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
55
AstraZeneca | Investor Event Presentation Deck | 55 slidesAstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
02
BenevolentAI | Investor Presentation Deck | 31 slidesBenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
04
The slide combines team bios with business model and partnership validation.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
05
Uses a structured layout to categorize problems into three pillars: cost/risk, time, and efficacy.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
06
BenevolentAI | Investor Presentation Deck | 31 slidesBenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
07
The slide uses a split-screen layout to contrast partnership-based revenue with internal pipeline development.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
08
The slide uses a process flow diagram to illustrate the drug discovery pipeline.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
09
The slide uses a circular arrow graphic to represent a feedback loop between in-silico and in-vitro processes.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
10
The slide uses a 'How we did it' process flow at the bottom to explain the underlying methodology.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
11
The slide uses a timeline on the left and a summary of partnership terms on the right.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
12
BenevolentAI | Investor Presentation Deck | 31 slidesBenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
13
The slide uses a Gantt-style chart to show the progress of different drug programs. It distinguishes between proprietary (teal) and partner (yellow) pipelines.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
14
Includes two process diagrams illustrating the Benevolent Platform's role and the experimental validation process.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
15
The slide uses a table to demonstrate market validation for early-stage IBD assets.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Market Size1 hit
16
The slide uses a causal chain logic to connect market deal activity and clinical unmet needs to the value proposition of the drug.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Loop · Why Now1 hit
17
The slide uses a two-row structure to contrast 'Collaborations' and 'Out licensing' business models.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
18
The slide uses a grid layout to present three distinct partner endorsements with associated logos and investment figures.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
19
The slide uses a grid layout to present financial KPIs.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Financials1 hit
21
BenevolentAI | Investor Presentation Deck | 31 slidesBenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
23
Includes a reference to Eroom's law, which describes the observation that drug discovery is becoming slower and more expensive over time.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Agitate (Make it worse)1 hit
24
The slide uses a split-screen approach to contrast two distinct value drivers: cost reduction and success rate improvement.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
25
The slide uses a table format to demonstrate differentiation and market potential for five specific pipeline assets.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
26
The slide outlines a standard clinical trial structure (SAD, Food Effect, MAD) and highlights the competitive advantage of a clean safety profile compared to historical PDE10 inhibitors.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
27
The slide emphasizes the absence of CNS-associated adverse events, which is a key differentiator for this PDE10 inhibitor.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
28
The slide uses a combination of text, scientific charts (dose-response curves), and a process diagram to validate the drug's mechanism.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
29
The slide uses a honeycomb/network diagram to represent data integration and processing.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
30
The slide uses a process flow diagram to map specific technical capabilities to stages of drug discovery.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
31
The slide uses a three-column layout to categorize value drivers: proprietary pipeline, partnerships, and future growth.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
01
Delivery Hero | Investor Presentation Deck | 54 slidesDelivery Hero | Investor Presentation Deck | 54 slides · Delivery Hero
Conference presentation Investor relations 1 hit